Weight loss

Suggested

7 studies · 1 recommendation

Last updated: February 25, 2026

Weight loss – Colorectal Cancer
Suggested7 studies

Weight management reduces colorectal cancer risk by up to 47% through lifestyle modification

Seven studies (4 cohort studies and 3 RCTs) involving over 57,000 participants consistently link excess body weight to elevated colorectal cancer risk and demonstrate that weight loss interventions effectively reduce that risk. Obesity increases gastrointestinal cancer risk by 30% (HR: 1.30, 95% CI: 1.05-1.60), while metabolic syndrome raises proximal colon cancer risk by 51% in men (HR: 1.51, 95% CI: 1.24-1.84). Visceral adipose tissue independently increases overall cancer risk by 22% beyond general adiposity. The BeWEL RCT showed that diet and physical activity interventions produced significant weight loss in colorectal adenoma patients at 12 months, with benefits consistent across socioeconomic groups. A feasibility RCT achieved 5% body weight loss in 36% of at-risk participants within 12 weeks. Population-level estimates indicate 45-47% of colorectal cancers are preventable through weight management and lifestyle modification.

Evidence

Authors: Borch, Kristin Benjaminsen, Laaksonen, Maarit A., Licaj, Idlir, Lukic, Marko, Rylander, Charlotta, Weiderpass, Elisabete

Published: August 22, 2022

In the NOWAC cohort of 35,525 Norwegian women, overweight and obesity (assessed by body mass index) contributed to colon cancer incidence as one of seven modifiable risk factors, though its individual population attributable fraction was described as small relative to smoking (18.7%) and alcohol (14.5%). Using a parametric piecewise constant hazards model accounting for competing risk of death, the seven factors jointly explained 46.0% (95% CI 23.0%-62.4%) of the colon cancer incidence burden, indicating substantial preventive potential through lifestyle modification.

Authors: Bakker, Stephan J.L., Benjamin, Emelia J., Cheng, Susan, de Bock, Geertruida H., de Boer, Rudolf A., Gansevoort, Ron T., Gruppen, Eke G., Ho, Jennifer E., Hoffmann, Udo, Hussain, Shehnaz K., Jovani, Manol, Kieneker, Lyanne M., Kreger, Bernard E., Larson, Martin G., Lau, Emily S., Levy, Daniel, Li, Shawn X., Liu, Elizabeth E., Meijers, Wouter C., Paniagua, Samantha M., Splansky, Greta Lee, Suthahar, Navin, Takvorian, Katherine S., van der Vegt, Bert, Vasan, Ramachandran S., Wang, Dongyu

Published: March 1, 2022

Among 20,667 participants followed for a median of 15 years, obesity was associated with a 30% increased risk of gastrointestinal cancer (HR: 1.30; 95% CI: 1.05-1.60). Waist circumference showed similar associations with gastrointestinal cancer. Higher C-reactive protein levels were specifically associated with increased colorectal and lung cancer risk (P < 0.05). Visceral adipose tissue was associated with a 22% increased risk of overall cancer (HR: 1.22; 95% CI: 1.05-1.43) independent of BMI, suggesting visceral fat plays a distinct mechanistic role beyond general adiposity.

Authors: Ahern, Anderson, Anderson, Anderson, Babor, Bambra, Barton, Bielderman, Brown, Cappuccio, Caswell, Clark, Craigie, De Irala-Estevez, Dowler, Drewnowski, Gordon, Hulshof, Lennernas, Murray, Nelson, Oliphant, Roberts, Roe, Roos, Rutherford, Sarlio-Lahteenkorva, Shah, Sheehy, Treweek, Wardle, Yancey

Published: May 15, 2018

The BeWEL randomized controlled trial enrolled 163 overweight adults diagnosed with colorectal adenoma into a 12-month diet and physical activity intervention. Intervention participants achieved significantly greater weight loss at 12 months compared to controls. When stratified by Scottish Index of Multiple Deprivation into more deprived (SIMD 1-2, n=58) and less deprived (SIMD 3-5, n=105) groups, no between-group differences were detected for changes in primary outcome (body weight) or main secondary outcomes (cardiovascular risk factors, diet, physical activity). This held despite baseline disparities in education (p=0.001), income (p<0.001), physical activity spending (p=0.003), and prior weight loss success (p=0.007). The study supports that up to 45% of colorectal cancer cases may be preventable through lifestyle and weight management.

Authors: Anderson, Annie S., Berg, Jonathan, Dunlop, Jacqueline, Gallant, Stephanie, Macleod, Maureen, Miedzybrodska, Zosia, Mutrie, Nanette, O’Carroll, Ronan E., Stead, Martine, Steele, Robert J. C., Taylor, Rod S., Vinnicombe, Sarah

Published: February 1, 2018

In this two-arm RCT of 78 overweight participants (BMI ≥25 kg/m²) with a family history of breast or colorectal cancer, 36% of the intervention group achieved the target of 5% body weight loss at 12 weeks compared to 0% in the control group. The intervention included one face-to-face counselling session, four telephone consultations, and web-based support with personalized diet and physical activity programs. Retention at 12 weeks was 76%, and the programme was rated as acceptable by participants in qualitative interviews.

Authors: Angela M. Craigie, Annie S. Anderson, Martine Stead, Maureen Macleod, Robert J. C. Steele, Stephen Caswell, The BeWEL Team

Published: January 1, 2015

In this randomized controlled trial enrolling 329 colorectal adenoma patients from the Scottish Bowel Screening Programme, participants randomized to a lifestyle intervention combining diet education, physical activity guidance, and behavioral change techniques achieved significantly better weight loss at 12-month follow-up compared to the control group. Baseline awareness of modifiable CRC risk factors was poor: mean knowledge score was 1.5 out of a possible 6 (SD 1.1), with 12% (n=40) unable to name any risk factors and 11% (n=36) unable to identify diet or activity-related factors. The study supports that approximately 47% of colorectal cancers are preventable through lifestyle modification including weight management.

Authors: Hveem, Kristian, Lu, Yunxia, Martling, Anna, Ness-Jensen, Eivind

Published: January 1, 2015

In the CONOR population-based cohort study conducted in Norway (1995-2010), anthropometric factors as metabolic syndrome components were significantly associated with colorectal adenocarcinoma. Metabolic syndrome defined by IDF criteria increased proximal colon cancer risk in men (HR = 1.51, 95% CI: 1.24-1.84) and rectal cancer risk in women (HR = 1.42, 95% CI: 1.07-1.89). ATP III-defined metabolic syndrome showed consistent results for men (HR = 1.40, 95% CI: 1.15-1.70) and women (HR = 1.43, 95% CI: 1.08-1.90). All single metabolic syndrome components except reduced HDL cholesterol and nonfasting glucose showed significant individual associations with colorectal adenocarcinoma.

Authors: Demark-Wahnefried, Wendy, Morey, Miriam C., Mosher, Catherine E., Rand, Kevin L., Snyder, Denise C., Winger, Joseph G.

Published: March 20, 2014

In a year-long randomized controlled trial (NCT00303875) of 641 older, overweight, long-term breast, prostate, and colorectal cancer survivors, a telephone and mailed print diet-exercise intervention produced a significant negative indirect effect on BMI (β = -0.06, p < 0.05). This effect was mediated through changes in dietary and exercise behavior during the intervention period. Session attendance was the key driver, with behaviors assessed at 14 time points demonstrating that consistent participation in both dietary and exercise components produced the BMI reduction.